Researchers identify a protein involved in the chromosomal disorder that could explain its characteristic learning deficits.
Advertisement
The Scientist
Most Recent
A presidential bioethics commission lays out the framework for testing the anthrax vaccine in children.
Next-generation sequencing diagnostics are already being used, and patients are ready.
Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.
Tailoring ethical oversight to participant-led research
Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
